Protecting Against Hearing Loss: Acousia Pursues A New Approach

 
• By John Davis

German biotech Acousia Therapeutics closes a series B round with corporate and institutional VC firms, and aims to advance its drugs into clinical trials for hearing loss associated with cancer chemotherapy.   

Inner ear
The inner ear is difficult to access and has a highly sophisticated spatial structure • Source: Shutterstock

More from Financing

More from Business